EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis

Xiuqi Hu, Mengdan Xu, Xiao Xiao, Ning Wang, Qianqian Zhang, Jianxian Ge, Jianfeng Zeng iD

Chemical & Biomedical Imaging · 2025-11-24 · 3 (11) · 702-714

DOI: 10.1021/cbmi.5c00055 ↗

At a glance

Übersichtsarbeit in Chemical & Biomedical Imaging, published online on 2025-07-10. Written by Xiuqi Hu and 6 co-authors. Institution: Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdiscip…. Cited 13 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Funding Program for Excellent Postdoctoral Talent.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Liver fibrosis, a progressive condition marked by excessive extracellular matrix deposition and activation of hepatic stellate cells, often develops asymptomatically in its early stages, leading to delayed clinical intervention. Conventional imaging techniques typically fail to detect mild fibrosis, resulting in diagnosis only at advanced stages such as cirrhosis, when therapeutic efficacy is significantly compromised. Recent advances in molecular imaging have facilitated the development of targeted contrast agents that enhance diagnostic sensitivity by selectively binding to fibrosis-specific biomarkers or responding to pathological microenvironmental changes. These include both nonresponsive probes that accumulate in fibrotic tissue and activatable probes sensitive to enzymes, small molecules, and other fibrosis-associated signals. This review systematically summarizes these emerging strategies and evaluates their potential for improving early diagnosis, staging accuracy, and therapeutic monitoring, thereby guiding future development and applications in hepatic fibrosis management.

Subjects

Author keywords

early diagnosisfibrosis biomarkershepatic stellate cellsliver fibrosismolecular imagingnonresponsive probesresponsive probes

Authors and institutions

  • Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiologic…
  • The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

ORCID profiles: Jianfeng Zeng

Funding

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • Suzhou Fundamental Research Project

Cite

APA

Hu, X., Xu, M., Xiao, X., Wang, N., Zhang, Q., Ge, J., & Zeng, J. (2025). Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis. Chemical & Biomedical Imaging, 3(11), 702-714. https://doi.org/10.1021/cbmi.5c00055

Vancouver

Hu X, Xu M, Xiao X, Wang N, Zhang Q, Ge J, et al. Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis. Chemical & Biomedical Imaging. 2025;3(11):702-714. doi:10.1021/cbmi.5c00055

BibTeX
@article{Hu2025,
  author = {Hu, Xiuqi and Xu, Mengdan and Xiao, Xiao and Wang, Ning and Zhang, Qianqian and Ge, Jianxian and Zeng, Jianfeng},
  title = {Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis},
  journal = {Chemical & Biomedical Imaging},
  year = {2025},
  volume = {3},
  number = {11},
  pages = {702--714},
  doi = {10.1021/cbmi.5c00055}
}
Start for free →